Clinical Trial Update: Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update on extended-release ropinirole for restless legs syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Ropinirole XR (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED